Pharmacy

EQS-News: Successful completion of a record year for Redcare Pharmacy: growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements.

Retrieved on: 
星期三, 三月 13, 2024

Successful completion of a record year for Redcare Pharmacy: growth 49%, adj.

Key Points: 
  • Successful completion of a record year for Redcare Pharmacy: growth 49%, adj.
  • EBITDA margin 3% for full year 2023, +3.7pp vs. 2022, with major improvements in both DACH and International segments.
  • Full-year guidance for 2024: continuation of both fast sales growth (30-40%) and solidly positive margins (adj.
  • Following positive margins in all four quarters, (iii) the adjusted EBITDA margin for the full year was 3% (guidance range of 1.5% to 3%).

EQS-News: Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).

Retrieved on: 
星期三, 三月 13, 2024

Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).

Key Points: 
  • Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).
  • Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).
  • Dirk Brüse and Lode Fastré, both long-standing managers at Redcare Pharmacy, are to succeed Stephan Weber and Marc Fischer as CCO and CIO.
  • Today, the Supervisory Board of Redcare Pharmacy agreed to the early departure request of the Managing Board members and founders Stephan Weber (CCO) and Marc Fischer (CIO).

Edison issues update on Georgia Capital (CGEO): FY23 NAV TR of 20% in sterling terms

Retrieved on: 
星期三, 三月 13, 2024

Georgia Capital (GCAP) reported a Q423 NAV total return (TR) of 7.7% in Georgian lari (GEL) terms (3.4% in sterling terms), bringing the FY23 NAV TR to a strong 26.5% (20.4% in sterling terms).

Key Points: 
  • Georgia Capital (GCAP) reported a Q423 NAV total return (TR) of 7.7% in Georgian lari (GEL) terms (3.4% in sterling terms), bringing the FY23 NAV TR to a strong 26.5% (20.4% in sterling terms).
  • The considerable increase in the sterling share price of Bank of Georgia (BoG) was the main contributor, adding c 5.1% and 19.5% to GCAP’s opening NAV in Q423 and FY23, respectively.
  • This was further assisted by positive revaluation of all large and investment-stage private holdings, except for the hospital business.
  • In aggregate, GCAP’s private holdings added 1.9pp to its Q423 NAV TR.

EQS-News: The Platform Group AG increases majority stake in ApoNow

Retrieved on: 
星期三, 三月 13, 2024

The Platform Group AG (ISIN DE000A200QEFA1 , “TPG”), a leading software company for platform solutions, has increased its majority stake in ApoNow GmbH (“ApoNow”) from 50.1% to 80.0%.

Key Points: 
  • The Platform Group AG (ISIN DE000A200QEFA1 , “TPG”), a leading software company for platform solutions, has increased its majority stake in ApoNow GmbH (“ApoNow”) from 50.1% to 80.0%.
  • Dr. Dominik Benner, CEO of The Platform Group AG: “ApoNow has developed positively since our entry in 2021 and is the only platform and software solution where pharmaceutical manufacturers are directly connected to local pharmacies.
  • In the current year, The Platform Group AG plans to acquire 3-8 companies in both the B2B and B2C sectors.
  • The Platform Group AG is a software company that is active in 19 sectors with its own platform solutions.

Liviniti Announces CEO LeAnn Boyd Named to Modern Healthcare's Women Leaders 2024 List

Retrieved on: 
星期一, 三月 11, 2024

Program honors women executives who influence care delivery and policy

Key Points: 
  • Natchitoches, Louisiana--(Newsfile Corp. - March 11, 2024) - Liviniti is proud to announce that LeAnn Boyd, CEO, has been recognized by Modern Healthcare as one of its Women Leaders for 2024.
  • As CEO and Co-founder of Liviniti, LeAnn has long challenged the pharmacy industry to adopt practices that make prescription drugs more affordable and accessible.
  • I am honored to be among the group of exceptional women named to Modern Healthcare's Women Leaders, 2024."
  • LeAnn C. Boyd, PharmD - CEO and Founder Wire Industry: Healthcare & Pharmaceutical
    To view an enhanced version of this graphic, please visit:

Liviniti Partners with Mindera Health to Improve Psoriasis Patient Care and Reduce Specialty Pharmacy Spend

Retrieved on: 
星期四, 二月 29, 2024

Innovative collaboration will improve patient outcomes and cost savings through reduced trial-and-error management of biologic therapies

Key Points: 
  • The program utilizes Mind.Px™, a dermal biomarker patch, to improve clinical outcomes while reducing biologic drug costs for self-funded employers.
  • "Inflammatory conditions are a major cost trend driver in the specialty pharmacy space," says LeAnn Boyd, Liviniti CEO.
  • "Leveraging pharmacogenomics through our collaboration with Mindera Health supports improved treatment outcomes for patients with psoriasis and reduced plan costs for expensive biologics.
  • "We are delighted to partner with a pharmacy benefit manager like Liviniti to introduce precision medicine to psoriasis patients," says Ron Rocca, President and CEO of Mindera Health.

LeAnn Boyd Named 2024 MM+M Pinnacle Awards Honoree

Retrieved on: 
星期三, 二月 28, 2024

Liviniti CEO selected for Pinnacle Awards class of 20 honorees from a diverse range of health and wellness organizations

Key Points: 
  • Natchitoches, Los Angeles--(Newsfile Corp. - February 28, 2024) - Liviniti is proud to announce that LeAnn Boyd, CEO, is part of the prestigious group of 20 healthcare leaders selected to receive the MM+M 2024 Pinnacle Awards.
  • Pinnacle Awards honorees will be profiled in the May print edition of MM+M and celebrated at an in-person event scheduled for May 2 in New York City.
  • LeAnn has long challenged the pharmacy industry to adopt practices that make prescription drugs more affordable and accessible.
  • "I am honored to be included as an MM+M Pinnacle Awards honoree among this group of transformative healthcare leaders," LeAnn comments.

LeAnn Boyd, Liviniti CEO, to Speak at NABIP Capitol Conference

Retrieved on: 
星期四, 二月 22, 2024

National conference highlights policies and issues shaping the future of healthcare

Key Points: 
  • Natchitoches, Louisiana--(Newsfile Corp. - February 22, 2024) - LeAnn Boyd, Liviniti CEO, is slated to speak at the National Association of Benefits and Insurance Professionals (NABIP) Capitol Conference on February 27.
  • Held at the Washington, D.C. Hyatt Regency on Capitol Hill, the 34th annual conference highlights healthcare issues that affect the health insurance industry and impact the roles of agents and brokers.
  • "The complex, ever-changing landscape of pharmacy benefits demands deep understanding and thoughtful solutions," LeAnn explains.
  • NABIP represents more than 100,000 licensed health insurance agents, brokers, general agents, consultants, and benefit professionals across the US.

Foundation Health Secures $6 Million in Seed Funding to Power the Next Generation of Consumer Healthcare Experiences

Retrieved on: 
星期一, 三月 11, 2024

SAN FRANCISCO, March 11, 2024 (GLOBE NEWSWIRE) -- Foundation Health, a pioneering healthcare technology company, today announced the closure of a $6 million seed funding round.

Key Points: 
  • SAN FRANCISCO, March 11, 2024 (GLOBE NEWSWIRE) -- Foundation Health, a pioneering healthcare technology company, today announced the closure of a $6 million seed funding round.
  • Foundation Health is dedicated to redefining the consumer healthcare experience by empowering clients to quickly develop and launch modern, digital-first pharmacy and telehealth solutions at scale.
  • "Our vision is to grow Foundation Health into the definitive tech platform for powering and managing complex consumer healthcare operations globally," said Foundation Health founder and CEO, Umar Afridi.
  • For more information about Foundation Health and its healthcare solutions, visit www.foundationhealth.com .

HIMALAYA TECHNOLOGIES PARTNERS WITH RENOVI! TO TARGET MEDICAL TOURISM MARKET IN CARIBBEAN; ADDS CEO TO ADVISORY BOARD

Retrieved on: 
星期一, 三月 11, 2024

Additionally, the Company has appointed Renovi!’s CEO, David Burns, Ph.D., to its Advisory Board to guide its entry into this multi-billion dollar market, assist on mergers and acquisitions including a potential combination of Renovi!

Key Points: 
  • Additionally, the Company has appointed Renovi!’s CEO, David Burns, Ph.D., to its Advisory Board to guide its entry into this multi-billion dollar market, assist on mergers and acquisitions including a potential combination of Renovi!
  • The availability of the newest medical technologies and the cheaper cost of treatment in emerging nations are key market drivers enhancing market growth.
  • reinvents traditional outpatient rehabilitation by offering patients a “recovery vacation” at an upscale, beachfront medical resort with healthy diet, exercise, community and exceptional medical care.
  • The Dominican Republic is uniquely positioned as a medical tourism destination because of its low costs, proximity to the U.S., a well-established tourism infrastructure, and tax incentives for tourism investments.